Follow us on
  • Linkedin
  • Twitter
  • Facebook
  • Google+

Zeev Zelig

15:00|Session 10 (Stage 1)

Bio Pharma Trends towards 2020

Zeev Zelig is Vice President, General Manager of Genzyme Israel and is also a Director of the Genzyme Rare Diseases Business in the ITC Region.

Before joining Genzyme in 1994, Zeev worked for Fissons and for Mediline. 
He was responsible for the establishment of the Genzyme subsidiaries in the Middle East, Turkey, Greece, Cyprus, and Romania, and held the position of Genzyme Corporation Patient Coordinator, coordinating between Genzyme and the various Patient Associations.

Zeev was the Chairman of the Board at Pharma-Israel, a founding member of ILSI (Israeli Life Science Industries). He is a member of the Board of the Merage Foundation which trains young Israeli Life Sciences managers, and a member of AMCHAM (America-Israel Chamber of Commerce) where he is active in the promotion of Israel-US cooperation in the Life Sciences Field.
Zeev is a member of the Israeli Export Institute Life Sciences Advisory Committee.
He served on the Steering Committee of the first Life Sciences Baltics Conference.